2-188988106-CT-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000090.4(COL3A1):c.555delT(p.Gly186ValfsTer36) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,788 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P185P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000090.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
- Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polymicrogyria with or without vascular-type Ehlers-Danlos syndromeInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000090.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL3A1 | NM_000090.4 | MANE Select | c.555delT | p.Gly186ValfsTer36 | frameshift | Exon 6 of 51 | NP_000081.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL3A1 | ENST00000304636.9 | TSL:1 MANE Select | c.555delT | p.Gly186ValfsTer36 | frameshift | Exon 6 of 51 | ENSP00000304408.4 | ||
| COL3A1 | ENST00000450867.2 | TSL:1 | c.555delT | p.Gly186ValfsTer36 | frameshift | Exon 6 of 50 | ENSP00000415346.2 | ||
| COL3A1 | ENST00000713745.1 | c.555delT | p.Gly186ValfsTer36 | frameshift | Exon 6 of 49 | ENSP00000519049.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460788Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726696 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
The c.555delT pathogenic variant in the COL3A1 gene has previously been reported in one individual with soft, velvety, translucent skin with atrophic scars, as well as multiple dissections involving the splenic and hepatic branches of the celiac artery and both renal arteries (Schwarze et al., 2001; Leistritz et al., 2011). This variant causes a shift in reading frame starting at codon glycine 186, changing it to a valine, and creating a premature stop codon at position 36 of the new reading frame, denoted p.Gly186ValfsX36. Moreover, mRNA studies demonstrated that c.555delT leads to the incorporation of a premature termination codon resulting in an unstable mRNA product that is rapidly degraded (Schwarze et al., 2001). Other downstream frameshift variants in the COL3A1 gene have been reported in HGMD in association with EDS type IV (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene. Furthermore, the c.555delT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).
Ehlers-Danlos syndrome, type 4 Pathogenic:2
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
The c.555delT pathogenic mutation, located in coding exon 6 of the COL3A1 gene, results from a deletion of one nucleotide at nucleotide position 555, causing a translational frameshift with a predicted alternate stop codon (p.G186Vfs*36). This variant was reported in individual(s) with features consistent with COL3A1-related Ehlers-Danlos syndrome (Schwarze U et al. Am J Hum Genet, 2001 Nov;69:989-1001; Leistritz DF et al. Genet Med, 2011 Aug;13:717-22; Shalhub S et al. J Vasc Surg Cases Innov Tech, 2023 Jun;9:101192; Demirdas S et al. Circ Genom Precis Med, 2024 Jun;17:e003978; Liu H et al. J Vasc Surg, 2025 Mar;81:557-565.e7). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Cardiovascular phenotype Pathogenic:1
PVS1, PM2, PS4_supp
Aortic dissection Pathogenic:1
ACMG-criteria applied: PVS1, PS3_Supporting, PS4_Moderate, PM2
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at